PAR 0.00% 22.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-300

  1. 252 Posts.
    lightbulb Created with Sketch. 33
    now that's interesting stats to me... so with that sort of fortune (NOT) , why is PAR not trying to get a cashed up partner to progress its work...and is the next cash raising going to work succesfully and provide the money they need to progress trials....I know a partnership results in LESS profits to the shareholders but we need a strong company that can weather the storm...No good having a weak company financially that continue to struggle to the finish line. Investors are and will continue to lose confidence if we don't pull our our heads out of the sand, and this could all turn to shit...I don't want to sound negative , and I am sure i am considered to be negative to many posters...but I am a realist and am pragmatic, and i see problems on the horizon if we dont get things happening that will influence the potential investment community.....wake up people... It can be a good result, but only with certain conditions attached. The wolves are watching closely...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.0¢ 23.5¢ 22.0¢ $66.95K 294.6K

Buyers (Bids)

No. Vol. Price($)
8 90092 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 25858 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.